Shots:

• The US FDA has granted EUA to the Vela’s PCR test that detects SARS-CoV-2 n nasopharyngeal and oropharyngeal swabs
• The manual version of the ViroKey enables flexible sample processing and quick adoption of the test by laboratories with existing ABI 7500 Fast Dx instruments but for high throughput testing- an automated version of the assay is used for the optimization  of a workflow consisting of the Sentosa SX101 instrument- in conjunction with ABI 7500 Fast Dx PCR instrument or the Sentosa SA201 instrument
• ViroKey SARS-CoV-2 RT-PCR Test has also received the CE mark and provisional approval from the Singapore Health Sciences Authority

­ Ref: Vela Diagnostic | Image: Biospectrum Asia